The incidence of Clostridium difficile infection (CDI) has been rising and its occurrence in Inflammatory Bowel Disease (IBD) is higher than the general population, yet there is no treatment protocol in these patients. Our study’s goal was to determine if there is a superior treatment regimen for CDI in IBD patients.